| Primary |
| Huntington's Disease |
38.2% |
| Product Used For Unknown Indication |
23.5% |
| Oral Disorder |
11.8% |
| Ballismus |
5.9% |
| Schizophrenia, Paranoid Type |
5.9% |
| Chorea |
2.9% |
| Depression |
2.9% |
| Dyspnoea |
2.9% |
| Speech Disorder |
2.9% |
| Tardive Dyskinesia |
2.9% |
|
| Agitation |
18.8% |
| Dystonia |
18.8% |
| Neoplasm Malignant |
12.5% |
| Joint Contracture |
6.3% |
| Paroxysmal Perceptual Alteration |
6.3% |
| Pneumonia |
6.3% |
| Suicidal Behaviour |
6.3% |
| Suicidal Ideation |
6.3% |
| Suicide Attempt |
6.3% |
| Therapeutic Response Decreased |
6.3% |
| Vision Blurred |
6.3% |
|
| Secondary |
| Product Used For Unknown Indication |
42.7% |
| Tourette's Disorder |
15.2% |
| Anxiety |
8.4% |
| Drug Use For Unknown Indication |
8.4% |
| Depression |
6.0% |
| Tic |
3.4% |
| Schizophrenia |
2.4% |
| Akathisia |
2.1% |
| Major Depression |
1.8% |
| Increased Appetite |
1.6% |
| Appetite Disorder |
1.0% |
| Decreased Appetite |
1.0% |
| Dystonia |
1.0% |
| Huntington's Chorea |
1.0% |
| Salivary Hypersecretion |
1.0% |
| Parkinsonism |
0.8% |
| Cerebral Palsy |
0.5% |
| Huntington's Disease |
0.5% |
| Muscle Spasms |
0.5% |
| Schizophrenia, Paranoid Type |
0.5% |
|
| Weight Increased |
33.3% |
| Muscle Contractions Involuntary |
18.2% |
| Multiple Drug Overdose Intentional |
10.6% |
| Thirst |
6.1% |
| Akathisia |
3.0% |
| Eating Disorder |
3.0% |
| Fall |
3.0% |
| Respiratory Failure |
3.0% |
| Suicidal Ideation |
3.0% |
| Affective Disorder |
1.5% |
| Atrial Fibrillation |
1.5% |
| Dehydration |
1.5% |
| Electrocardiogram Abnormal |
1.5% |
| Feeling Abnormal |
1.5% |
| Hallucination |
1.5% |
| Parkinsonism |
1.5% |
| Persecutory Delusion |
1.5% |
| Photophobia |
1.5% |
| Salivary Hypersecretion |
1.5% |
| Sedation |
1.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
42.3% |
| Depression |
8.5% |
| Tardive Dyskinesia |
5.9% |
| Drug Use For Unknown Indication |
4.9% |
| Muscle Spasms |
4.9% |
| Schizophrenia |
4.6% |
| Blood Cholesterol Increased |
3.9% |
| Type 2 Diabetes Mellitus |
3.9% |
| Hypertension |
2.6% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Movement Disorder |
2.3% |
| Neuropathy Peripheral |
2.3% |
| Blood Pressure Increased |
2.0% |
| Anxiety |
1.6% |
| Hyperthyroidism |
1.6% |
| Psychotic Disorder |
1.6% |
| Decreased Appetite |
1.3% |
| Eructation |
1.3% |
| Delusional Disorder, Persecutory Type |
1.0% |
| Fracture |
1.0% |
|
| Tardive Dyskinesia |
13.2% |
| Weight Decreased |
7.9% |
| Dyspnoea |
5.3% |
| Eating Disorder |
5.3% |
| Incorrect Dose Administered |
5.3% |
| Iron Deficiency Anaemia |
5.3% |
| Muscle Contractions Involuntary |
5.3% |
| Myocarditis |
5.3% |
| Poor Quality Sleep |
5.3% |
| Schizophrenia, Catatonic Type |
5.3% |
| Sinus Tachycardia |
5.3% |
| Skin Exfoliation |
5.3% |
| Weight Increased |
5.3% |
| White Blood Cell Count Decreased |
5.3% |
| Abdominal Discomfort |
2.6% |
| Aggression |
2.6% |
| Alopecia |
2.6% |
| Anxiety |
2.6% |
| Atrioventricular Block |
2.6% |
| Bradycardia |
2.6% |
|
| Interacting |
|
| Somnolence |
50.0% |
| Vomiting |
50.0% |
|
